A comparative study between a brain Na+,K+-ATPase inhibitor (endobain E) and ascorbic acid

Neurochemical Research

Volumn 28, Issue 6, 2003, Pages 903-910

  Rodriguez de Lores Arnaiz G ^a   Herbin, T ^a   Pena C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Ascorbic acid; Endobain; K+ p nitrophenylphosphatase inhibitor; Na+,K+ ATPase inhibitor

Indexed keywords

4 NITROPHENYLPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ASCORBIC ACID; CYSTEINE; ENDOBAIN E; IODINE; POTASSIUM 4 NITROPHENYLPHOSPHATASE; UNCLASSIFIED DRUG;

ABSORPTION; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME INHIBITION; GEL FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET RADIATION;

4-NITROPHENYLPHOSPHATASE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BRAIN; CYSTEINE; IODINE; KINETICS; MALE; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ULTRAVIOLET;

ANIMALIA;

EID: 0346037248     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023227510707     Document Type: Article

References (44)

1. Stahl, W. 1986. The Na,K-ATPase of nervous tissue. Neurochem. Int. 8:449-476.
2. Albers, R. W. and Siegel, G. J. 1999. Membrane transport. Pages 95-118, in Siegel G. J., Agranoff, B. W., Albers, R. W., Fisher, S. K., and Uhler, M. D., (eds.), Basic Neurochemistry, Lippincott-Raven, Philadelphia, PA.
3. Rodríguez de Lores Arnaiz, G., Alberici, M., and De Robertis, E. 1967. Ultrastructural and enzymic studies of cholinergic and non-cholinergic synaptic membranes isolated from brain cortex. J. Neurochem. 14:215-225.
4. +-ATPase regulators. Mol. Neurobiol. 6:359-375.
5. Goto, A., Yamada, K., Yagi, N., Yoshioka, M., and Sugimoto, T. 1992. Physiology and pharmacology of endogenous digitalislike factors. Pharmacol. Rev. 44:377-399.
6. Glynn, I. M. 1963. Transport of adenosine triphosphatase in electric organ: The relationship between ion transport and oxidative phosphorylation J. Physiol. Lond. 169:452-465.
7. Inagaki, C. 1970. Inhibition of Mg, Na, K-activated adenosine triphosphatase activity by L-ascorbic acid and L-cysteine. Japan J. Pharmacol. 20:52-60.
8. +-adenosine triphosphate phosphohydrolase complexes of several tissues. Biochem. Pharmacol. 22:9-15.
9. Schaefer, A., Seregi, A., and Komlos, M. 1974. Ascorbic acidlike effect of the soluble fraction of rat brain on adenosine triphosphatases and its relation to catecholamines and chelating agents. Biochem. Pharmacol. 23:2257-2271.
10. Schaefer, A., Komlos, M., and Seregi, A. 1975. Lipid peroxidation as the cause of the ascorbic acid induced decrease of adenosine triphosphatase activities of rat brain microsomes and its inhibition by biogenic amines and psychotropic drugs. Biochem. Pharmacol. 24:1781-1786.
11. +-ATPase. Biochem. Pharmacol. 34:2525-2530.
12. Kuske, R., Moreth, K., Renner, D., Wizemann, V., and Schoner, W. 1987. Sodium pump inhibitor in the serum of patients with essential hypertension and its partial purification from hemofiltrate. Klin. Wochenschr. 65(Suppl. 8):53-59.
13. Rodríguez de Lores Arnaiz, G., Antonelli de Gómez de Lima, M., and Girardi, E. 1988. Different properties of two brain fractions separated in Sephadex G-50 that modify synaptosomal ATPase activities. Neurochem. Res. 3:229-235.
14. +-ATPase. Life Sci. 47:1091-1098.
15. +-ATPase modifiers on high-affinity ouabain binding determined by quantitative autoradiography. J. Neurosci. Res. 28:342-331.
16. +-ATPase. Micr. Electr. Biol. Cell 15:93-106.
17. +. Neurochem. Res. 18:655-661.
18. +-ATPase inhibitors. Neurochem. Int. 27:319-327.
19. Rodríguez de Lores Arnaiz, G. 2000. How many endobains are there? Neurochem. Res. 25:1421-1430.
20. +-ATPase inhibitor (endobain E) enhances norepinephrine release in rat hypothalamus. Neuroscience 90:573-579.
21. +-ATPase. Neurochem. Res. 11:933-947.
22. Albers, R. W., Rodríguez de Lores Arnaiz, G., and De Robertis, E. 1965. Sodium-potassium-activated ATPase and potassium-activated p-nitrophenylphosphatase: a comparison of their subcellular localizations in rat brain. Proc. Natl. Acad. Sci. USA 53:557-564.
23. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
24. Szent-Györgyi, A. 1928. Observations on the function of peroxidase systems and the chemistry of the adrenal gland: Description of a new carbohydrate derivative. Biochem. J. 22:1387-1409.
25. Marcus, R. and Coulston, A. M. 1996. The vitamins. Pages 1547-1590, in Hardman, J. G. and Limbird, L. E. (eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York.
26. Basse-Tomusk, A. and Rebec, G. V. 1990. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum. Pharmacol. Biochem. Behav. 35:55-60.
27. Ghasemzadeh, B., Cammack, J., Adams, R. N., and Ghasemzedah, B. 1991. Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry. Brain Res. 547:162-166.
28. Pierce, R. C. and Rebec, G. V. 1993. Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via non-dopaminergic mechanisms. J. Neurosci. 13:4272-4280.
29. Rebec, G. V. and Pierce, R. C. 1994. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 43:537-565.
30. Morel, P., Fauconneau, B., Page, G., Mirbeau, T., and Huget, F. 1998. Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: Relationship to lipid peroxidation and oxidation of protein sulfhydryl groups. Neurosci. Res. 32:171-179.
31. Lester, H. A., Mager, S., Quick, M. W., and Corey, J. L. 1994. Permeation properties of neurotransmitter transporters. Annu. Rev. Pharmacol. Toxicol. 34:219-249.
32. Boutelle, M. G., Svensson, L., and Fillenz, M. 1989. Rapid changes in striatal ascorbate in response to tail-pinch monitored by constant potential voltammetry. Neuroscience 30:11-17.
33. O'Neill, R. D., Fillenz, M., and Albery, W. J. 1982. Circadian changes in homovanillic acid and ascorbate levels in the rat striatum using microprocessor-controlled voltammetry. Neurosci. Lett. 34:189-193.
34. Kiyatkin, E. A. and Rebec, G. V. 1998. Ascorbate modulates glutamate-induced excitations of striatal neurons. Brain Res. 812:14-22.
35. Kiyatkin, E. A. and Rebec, G. V. 1996. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J. Neurophysiol. 75:142-153.
36. Majewska, M. D., Bell, J. A., and London, E. D. 1990. Regulation of the NMDA receptor by redox phenomena: Inhibitory role of ascorbate. Brain Res. 537:328-332.
37. +-ATPase inhibitor: Comparison with ouabain. Neurochem. Int. 39:301-310.
38. +-ATPase inhibitor. J. Neurochem. 78 (Suppl. 1):BP18-44.
39. Svoboda, P. and Mosinger, B. 1981. Catecholamines and the brain microsomal Na, K-adenosinetriphosphatase: I. Protection against lipoperoxidative damage. Biochem. Pharmacol. 30:427-432.
40. 2+ inhibition of Na,K-ATPase. Biochem. Pharmacol. 33:2493-2497.
41. Goto, K. and Tanaka, R. 1981. Ascorbic acid inhibition of Na,K-adenosine triphosphatase of rat forebrain without peroxidation of membrane lipids. Brain Res. 207:239-244.
42. +-ATPase inhibitor. J. Neurochem. 74(Suppl.):S65B.
43. +-ATPase inhibitor enhances phosphoinositide hydrolysis in neonatal but not in adult rat brain cortex. Neurochem. Res. 26:1253-1259.
44. +-ATPase interaction with a brain endogenous inhibitor (endobain E). Neurochem. Int. 33:425-433.